Related Experiment Videos
Oral albendazole for the treatment of cutaneous larva migrans
S K Jones1, N J Reynolds, S Oliwiecki
1Department of Dermatology, Bristol Royal Infirmary, Bristol, U.K.
The British Journal of Dermatology
|January 1, 1990
Abstract:
Cutaneous larva migrans is becoming more common in the U.K. with the popularity of tropical countries as holiday destinations. We describe the increasing use of a new benzimidazole derivative, albendazole, which is very effective in the treatment of cutaneous larva migrans. In contrast to thiabendazole, it is virtually free from side-effects and should, we feel, become the treatment of choice for this condition.